DDX3X and Ewing sarcoma: In medulloblastoma cell lines, as for prostate cancer and Ewing sarcoma, the treatment with the DDX3X inhibitor RK-33 reduces cell growth by reducing transcript levels of Wnt-regulated genes [44].